Kaleido Biosciences

NASDAQ: KLDO

Initial Filing Date: 01/11/19

Launch Date: 02/19/19

Pricing Date: 02/27/19

IPO Price: $15.00

Price Range: $20.00 - $22.00

Initial Shares Offered (mm): 4.8

Shares Offered (Pre-Shoe | mm): 5.0

Primary Shares (mm): 5.0

Amount Offered (mm): $75.0

% Secondary: 0.0%

Shares Outstanding (mm): 29.4

Market Value at Pricing (mm): $440.9

Offering as % of Market Value: 17.0%

Bookrunners: GS | JPM | MS

Co-Manager: Canaccord

Major Holders: Flagship Pioneering Funds | Platinum Falcon B | Michael Bonney

Industry: Healthcare

Description: Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health

Note: Emerging Growth Company

Reference Link: Press Release